Article Information
History
- October 24, 2019.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Xiaofen Zheng1,2,*,
- Bingbing Xie3,*,
- Yan Liu1,
- Ming Zhu1,
- Shu Zhang1,
- Chengjun Ban4,
- Jing Geng3,
- Dingyuan Jiang3,
- Yanhong Ren3,
- Huaping Dai3,† and
- Chen Wang3
- 1Department of Pulmonary and Critical Care Medicine, Beijing Chao-Yang Hospital, Capital Medical University, Beijing, China
- 2The Second Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, China
- 3Department of Pulmonary and Critical Care Medicine, Center of Respiratory Medicine, China-Japan Friendship Hospital; National Clinical Research Center for Respiratory Diseases; Institute of Respiratory Medicine, Chinese Academy of Medical Sciences, Peking Union Medical College; Beijing, China
- 4Department of Respiration of Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, China
- ↵†Correspondence to:
Huaping Dai, MD, Department of Pulmonary and Critical Care Medicine, Center of Respiratory Medicine, China–Japan Friendship Hospital, Beijing, 100029, P.R. China. E-mail: daihuaping{at}ccmu.edu.cn, Tel/Fax: +86-10-84206271
↵* they contributed equally to this study.
Posted October 24, 2019.
Direct medical costs of hospitalized patients with idiopathic pulmonary fibrosis in China
